Phase II Objective:

The objective of Phase II of this study is to evaluate the effect of the supplement Sefacon, on equine diagnosed positive for EPM under the guidelines set forth in EPM Protocol Objective.  The scope of the evaluation was limited to 5 EPM positive equine.

Phase II Conclusion:

From the information gathered in this phase of the study, the supplement Sefacon™ has the following effects:

1. 100 percent success with regards to stopping the progression of the disease, in so much as no horse’s condition continued to deteriorate after administration began.
2. 100 percent success with regards to overall improvement of the horse’s condition as all 5 equine improved in all areas of deficit.